Joel Greenblatt's THC Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 109,667 shares of Tenet Healthcare Corporation (THC) worth $21.79 M, representing 0.08% of the portfolio. First purchased in 2015-Q2, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in THC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2016, adding 545,902 shares. Largest reduction occurred in Q3 2016, reducing 523,413 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Tenet Healthcare Corporation (THC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenet Healthcare Corporation (THC) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +77,501 | Add 240.94% | 109,667 | $198.72 |
| Q3 2025 | +12,575 | Add 64.19% | 32,166 | $203.04 |
| Q2 2025 | -1,711 | Reduce 8.03% | 19,591 | $176.00 |
| Q1 2025 | -92,879 | Reduce 81.34% | 21,302 | $134.50 |
| Q4 2024 | +41,978 | Add 58.14% | 114,181 | $126.23 |
| Q3 2024 | -14,620 | Reduce 16.84% | 72,203 | $166.20 |
| Q2 2024 | +48,741 | Add 127.99% | 86,823 | $133.03 |
| Q1 2024 | -8,784 | Reduce 18.74% | 38,082 | $105.11 |
| Q4 2023 | +10,674 | Add 29.49% | 46,866 | $75.57 |
| Q3 2023 | +29,547 | Add 444.65% | 36,192 | $65.89 |
| Q2 2023 | +70 | Add 1.06% | 6,645 | $81.38 |
| Q4 2022 | -11 | Reduce 0.17% | 6,575 | $48.79 |
| Q3 2022 | -15,518 | Reduce 70.20% | 6,586 | $51.62 |
| Q2 2022 | +12,318 | Add 125.87% | 22,104 | $52.57 |
| Q1 2022 | -28,990 | Reduce 74.76% | 9,786 | $85.94 |
| Q4 2021 | +26,063 | Add 205.01% | 38,776 | $81.70 |
| Q3 2021 | -16,776 | Reduce 56.89% | 12,713 | $66.47 |
| Q2 2021 | +5,757 | Add 24.26% | 29,489 | $66.97 |
| Q1 2021 | -23,321 | Reduce 49.56% | 23,732 | $52.00 |
| Q4 2020 | -9,177 | Reduce 16.32% | 47,053 | $39.93 |
| Q3 2020 | -40,639 | Reduce 41.95% | 56,230 | $24.51 |
| Q2 2020 | +96,869 | New Buy | 96,869 | $18.11 |
| Q1 2020 | -5,927 | Sold Out | 0 | $0.00 |
| Q4 2019 | +5,927 | New Buy | 5,927 | $37.96 |
| Q2 2019 | -126,104 | Sold Out | 0 | $0.00 |
| Q1 2019 | -59,718 | Reduce 32.14% | 126,104 | $28.84 |
| Q4 2018 | -105,041 | Reduce 36.11% | 185,822 | $17.14 |
| Q3 2018 | +13,224 | Add 4.76% | 290,863 | $28.46 |
| Q2 2018 | -54,011 | Reduce 16.29% | 277,639 | $33.57 |
| Q1 2018 | -107,624 | Reduce 24.50% | 331,650 | $24.25 |
| Q4 2017 | +358,885 | Add 446.44% | 439,274 | $15.16 |
| Q3 2017 | +80,389 | New Buy | 80,389 | $16.43 |
| Q4 2016 | -22,489 | Sold Out | 0 | $0.00 |
| Q3 2016 | -523,413 | Reduce 95.88% | 22,489 | $22.68 |
| Q2 2016 | +545,902 | New Buy | 545,902 | $27.64 |
| Q3 2015 | -20,284 | Sold Out | 0 | $0.00 |
| Q2 2015 | +20,284 | New Buy | 20,284 | $57.88 |
Joel Greenblatt's Tenet Healthcare Corporation Investment FAQs
Joel Greenblatt first purchased Tenet Healthcare Corporation (THC) in Q2 2015, acquiring 20,284 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Tenet Healthcare Corporation (THC) for 38 quarters since Q2 2015.
Joel Greenblatt's largest addition to Tenet Healthcare Corporation (THC) was in Q2 2016, adding 545,902 shares worth $15.09 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 109,667 shares of Tenet Healthcare Corporation (THC), valued at approximately $21.79 M.
As of the Q4 2025 filing, Tenet Healthcare Corporation (THC) represents approximately 0.08% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Tenet Healthcare Corporation (THC) was 545,902 shares, as reported at the end of Q2 2016.